Close Menu

NEW YORK – Public Health England has chosen PerkinElmer as a provider of a newborn screening test for severe combined immunodeficiency (SCID) as part of a collaboration with Public Health England's SCID evaluation program, the company said on Friday.

Public Health England will use PerkinElmer's Victor EnLite instrument and EnLite Neonatal TREC kit at three of six sites to evaluate screening newborns for the rare inherited genetic disease, sometimes called "Bubble Boy" disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.